$XORTX Therapeutics Inc.(XRTX)$  There’s great news circulating about Xortx Therapeutics (NASDAQ:XRTX) today. In a clinical study, XORLO, Xortx’s orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. This news caused a huge spike in XRTX stock this morning, though it has since lost some momentum.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论